CIMBALI
Sunday 22 December 2024
  • La Cimbali

GenTech reports 824% growth in assets for three months ended July 31

Must read

  • Dalla Corte
TME - Cialdy Evo
Demuslab

NEW YORK, U.S. – GenTech Holdings, Inc. (“GenTech” or the “Company”), an emerging leader in the high-end Premium Coffee and Functional Foods marketplaces, has announced operational performance data for the three months ended July 31, 2020.

Highlights Include over $300k in Purchase Orders for the three months ended July 31, with $151,630 booked as gross sales (both Company records).

Total assets as of July 31 stood at $446,959 (versus $48,351 as of April 30, 2020), representing an increase of 824% on a sequential quarterly basis and 2,200% annually

Cash was up 2,580% on a sequential quarterly basis, and up over 6,700% annually. Inventory was valued at $62,500 of July 31. Accounts receivable valued at $86,293 of July 31.

“As anticipated in prior releases, the turning point for GenTech, in terms of the establishment of robust and accelerating growth, came with our landmark acquisition of Sinister Labs, LLC, and the Sinfit Nutrition brand, which closed in June,” commented David Lovatt, CEO of GenTech.

“This is a strong and growing brand with a massive domestic and international distribution footprint in the booming functional foods market space. Our July quarter set multiple Company records. Our October quarter is on pace to handily set new ones.”

Management notes that the Company also announced a 43% increase in total outstanding GenTech common shares during the three months ended July 31, 2020, which represents the overall equity cost of the Sinfit acquisition.

However, the Company urges shareholders to view this information in context. This increase in total outstanding shares is already being balanced by sharp growth in cash, assets, sales, and the overall business backed by that equity.

Lovatt continued, “We understand concerns over dilution. It’s natural to view an increase in outstanding shares as a negative event. But acquisitions aren’t free, and growth comes at an upfront cost. When it works out, we call it an investment. Our current growth is coming through an equity investment, rather than one levied in debt, which is ultimately desirable. Note that, in simple terms, our total liabilities held steady from April to July while our total assets grew by over 800%. We anticipate this growth to continue and likely accelerate over the coming twelve months. And we continue to project a potential for over $3 million in sales in 2021, which is simply an extrapolation from our current performance and recent growth trend.”

CIMBALI

Latest article

  • Franke Mytico
Demus Art of decaffeination